Related Experiment Video
Updated: Jun 22, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
The subaortic tendon as a mimic of hypertrophic cardiomyopathy
1Department of Physiology, University of Pretoria, Pretoria, South Africa, Gesina, Pretoria, South Africa 0031. jker@wol.co.za
Insights
Left ventricular false tendons can mimic hypertrophic cardiomyopathy (HCM) on echocardiograms. Differentiating these structures is crucial to avoid misdiagnosing HCM and ensure accurate patient care.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is defined as ventricular hypertrophy without secondary causes.
- HCM exhibits significant genetic and phenotypic heterogeneity, with over 300 mutations identified across 24 genes.
- The disease presentation varies widely, affecting different parts of the ventricles.
Observation:
- Left ventricular false tendons are fibrous structures within the ventricular cavity.
- A specific case highlighted a subaortic false tendon causing ST-segment elevation on ECG.
- Another case demonstrated a subaortic tendon mimicking the echocardiographic features of HCM.
Findings:
- Subaortic false tendons can present with echocardiographic findings characteristic of hypertrophic cardiomyopathy.
- These findings can lead to a false positive diagnosis of HCM if not properly identified.
Implications:
- Accurate differentiation between false tendons and true HCM is essential for correct diagnosis.
- Exclusion of left ventricular false tendons is critical in the assessment of suspected hypertrophic cardiomyopathy.
- This distinction prevents misdiagnosis and ensures appropriate patient management.
Abstract:
Originally described by Brock and Teare, today hypertrophic cardiomyopathy is clinically defined as left (or right) ventricular hypertrophy without a known cardiac or systemic cause, such as systemic hypertension, Fabry's disease or aortic stenosis.Also appreciated today is the enormous genotypic and phenotypic heterogeneity of this disease with more than 300 mutations over more than 24 genes, encoding various sarcomeric, mitochondrial and calcium-handling proteins, all as genetic causes for hypertrophic cardiomyopathy.Phenotypically, the disease can vary from negligible to extreme hypertrophy, affecting either the left and/or right ventricle in an apical, midventricular or subaortic location.Left ventricular false tendons are thin, fibrous or fibromuscular structures that traverse the left ventricular cavity. Recently, a case report was presented where it was shown that such a false tendon, originating from a subaortic location, was responsible for striking ST-segment elevation on the surface electrocardiogram.In this case report, a case is presented where such a subaortic tendon led to the classic echocardiographic appearance of hypertrophic cardiomyopathy, thus in the assessment of hypertrophic cardiomyopathy, this entity needs to be excluded in order to prevent a false positive diagnosis of hypertrophic cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction

